Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Thymus daenensis extract* is a phytopharmaceutical and dietary supplement derived from the aerial parts of the Thymus daenensis plant, an endemic species of thyme native to Iran. The extract is rich in phenolic and flavonoid compounds, with major components including thymol, carvacrol, linalool, and other terpenoids and aromatics[1][2][3]. This extract exhibits notable antimicrobial, antifungal, antioxidant, and radical scavenging properties, as well as genoprotective effects, which are dose dependent[1][2]. Preclinical and limited clinical research demonstrates its potential roles in alleviating symptoms of morphine withdrawal (putatively via modulation of the opioid system), improving inflammation, and promoting wound healing[3][4]. Thymus daenensis extract is not a pharmaceutical drug and is used primarily in folk medicine and research settings for digestive, antitussive, antispasmodic, expectorant, antimicrobial, and antioxidant purposes[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thymus daenensis extract.